LOGIN  |  REGISTER
Assertio

BUY $ASRT

Buy $ASRT on Charles Schwab

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024

October 11, 2024 | Last Trade: US$0.83 0.03 -3.59

LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Brendan O’Grady, Chief Executive Officer, will participate in a fireside chat discussion as part of the Maxim Group 2024 Healthcare Virtual Summit. The fireside chat with Mr. O’Grady, hosted by Maxim Group research analyst Naz Rahman, will occur Tuesday, October 15, 2024 at 1:00 pm Eastern Time.

Investors can register to listen to the event via https://m-vest.com/events/healthcare-10152024.

About Assertio

Assertio is a commercial pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.

Investor Contact

Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
This email address is being protected from spambots. You need JavaScript enabled to view it.

BUY $ASRT

Buy $ASRT on Charles Schwab

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Stock Quote

BUY $ASRT

Buy $ASRT on Charles Schwab

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...

CLICK TO LEARN MORE
Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page